PP
XENT

PDT Partners’s Intersect ENT, Inc XENT Stock Holding History

PDT Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,338
Closed -$799K – 600
2018
Q1 		$799K Sell
20,338
-36,082
-64% -$1.32M 0.03% 384
2017
Q4 		$1.83M Sell
56,420
-12,780
-18% -$383K 0.05% 308
2017
Q3 		$2.16M Hold
69,200
– – 0.07% 270
2017
Q2 		$1.93M Buy
69,200
+30,700
+80% +$695K 0.08% 258
2017
Q1 		$660K Buy
38,500
+15,057
+64% +$211K 0.03% 354
2016
Q4 		$284K Buy
+23,443
New +$303K 0.02% 443

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PDT Partners's XENT Position: Q2 2018 in Review

PDT Partners sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 20,338 shares — an estimated $799K sold.

PDT Partners first reported a position in XENT in Q4 2016 and held it in 6 quarters. The position peaked at $2.16M in Q3 2017. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • PDT Partners reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • PDT Partners sold 20,338 Intersect ENT, Inc shares in Q2 2018, an estimated $799K.
  • PDT Partners first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 6 quarters.
  • PDT Partners's Intersect ENT, Inc position peaked at $2.16M in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on PDT Partners's 13F filing for Q2 2018, filed 14 Aug 2018.